greeksoup/ stock research

Ecovyst Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 26 February 2026: press release. Guidance figures: 8 new. The quarter’s numbers.

Key takeaways

  • Fourth-quarter sales increased: Sales were $199.4 million, compared with $148.9 million a year earlier, a 33.9% increase. Source
  • Fourth-quarter Adjusted EBITDA rose: Adjusted EBITDA was $51.3 million against $47.7 million a year earlier; management cited favorable volume and pricing at the sales level. Source
  • Virgin acid volume rose with Waggaman: Higher virgin sulfuric acid sales, including the acquired Waggaman location, drove the volume increase for the year. Source
  • Full-year Adjusted EBITDA margin fell: Full-year Adjusted EBITDA margin was 23.8%, against 28.9% in 2024, on Adjusted EBITDA of $172.0 million versus $172.7 million. Source
  • Regenerated volume expected to grow: Management expects high refinery utilization, positive alkylate economics and lower customer downtime versus 2025 to increase regenerated acid sales in 2026. Source
  • Mining demand seen driving virgin growth: Management expects strong mining demand to drive year-over-year growth in virgin acid sales in 2026. Source
  • Operating cash flow rose: Continuing operations produced $118.1 million of operating cash flow in 2025, up from $103.8 million; including discontinued operations the total was $140.3 million. Source
  • Full-year buybacks totaled $47.4 million: The company repurchased 5,752,285 shares in 2025 for $47.4 million, excluding brokerage commissions and accrued excise tax. Source

“We enter the year with a strong balance sheet, substantial liquidity and a favorable historic cash generation profile”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Sales SourceFull year 2026$860 million to $940 millionNew
Adjusted EBITDA SourceFull year 2026$175 million to $195 millionNew
Adjusted Free Cash Flow SourceFull year 2026$35 million to $55 millionNew
Capital expenditures SourceFull year 2026$80 million to $90 millionNew
Interest expense SourceFull year 2026$18 million to $22 millionNew
Depreciation & Amortization SourceFull year 2026$78 million to $82 millionNew
Effective tax rate SourceFull year 2026mid 20% rangeNew
Adjusted Net Income and Adjusted Diluted Income per share SourceFull year 2026$55 million to $75 million; $0.45 to $0.65 per shareNew

What changed from last quarter

  • New guidance: Full-year 2026 guidance was issued for sales, Adjusted EBITDA, cash flow, capital expenditures, interest, depreciation and amortization, tax rate and net income. Source
  • Ended: The Advanced Materials & Catalysts segment was sold; the third-quarter release had described the sale as pending, expected to close in the first quarter of 2026. Source

Fourth quarter and full-year results

  • Fourth-quarter sales increased: Sales were $199.4 million, compared with $148.9 million a year earlier, a 33.9% increase. Source
  • Fourth-quarter Adjusted EBITDA rose: Adjusted EBITDA was $51.3 million against $47.7 million a year earlier; management cited favorable volume and pricing at the sales level. Source
  • Full-year sales increased: Full-year sales were $723.5 million, up from $598.3 million, a 20.9% increase. Source
  • Continuing net income fell: Net income from continuing operations was $6.3 million, or $0.05 diluted per share, against $45.5 million in 2024; the net loss including discontinued operations was $71.1 million. Source

Sales drivers: sulfur, volume and pricing

  • Sulfur pass-through lifted average prices: Higher average selling prices reflected about $77 million of pass-through from higher sulfur costs for the full year. Source
  • Virgin acid volume rose with Waggaman: Higher virgin sulfuric acid sales, including the acquired Waggaman location, drove the volume increase for the year. Source
  • Regenerated acid contract pricing improved: Favorable contract pricing for regenerated sulfuric acid added to full-year sales. Source

“Our focus in 2026 will remain on positioning Ecovyst for profitable long-term growth and delivering value for our stockholders.”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Costs and margins

  • Full-year Adjusted EBITDA margin fell: Full-year Adjusted EBITDA margin was 23.8%, against 28.9% in 2024, on Adjusted EBITDA of $172.0 million versus $172.7 million. Source
  • Waggaman assets added manufacturing costs: Fourth-quarter manufacturing costs rose with incremental costs of the acquired Waggaman assets. Source
  • Full-year Adjusted Net Income was $45.7 million: Adjusted Net Income was $45.7 million, with Adjusted Diluted Income per share of $0.39, down from $51.7 million in 2024 per the reconciliation table. Source

Demand and 2026 expectations

  • Regenerated volume expected to grow: Management expects high refinery utilization, positive alkylate economics and lower customer downtime versus 2025 to increase regenerated acid sales in 2026. Source
  • Mining demand seen driving virgin growth: Management expects strong mining demand to drive year-over-year growth in virgin acid sales in 2026. Source
  • Demand fundamentals seen positive: Management anticipates demand fundamentals to remain positive for both regeneration services and virgin acid sales in 2026. Source

Cash flow and balance sheet

  • Operating cash flow rose: Continuing operations produced $118.1 million of operating cash flow in 2025, up from $103.8 million; including discontinued operations the total was $140.3 million. Source
  • Adjusted free cash flow reached $78.1 million: Adjusted free cash flow was $78.1 million, against $85.5 million in 2024; adjustments added back $17.6 million of segment disposal costs and $6.1 million of Waggaman costs. Source
  • Divestiture proceeds repaid Term Loan: The company used $465 million of divestiture net proceeds to pay down the Term Loan, leaving gross debt of $397.1 million and cash of $197.2 million. Source
  • Net debt leverage at 1.2x: Net debt leverage ratio was 1.2x at year-end, down from 4.3x a year earlier; total available liquidity was $264.8 million. Source

Share repurchases and authorization

  • Full-year buybacks totaled $47.4 million: The company repurchased 5,752,285 shares in 2025 for $47.4 million, excluding brokerage commissions and accrued excise tax. Source
  • Fourth-quarter buybacks totaled $20.0 million: The company repurchased 2,215,921 shares in the fourth quarter, at an average price of $9.03 per share. Source
  • $182.2 million left under program: Remaining availability under the $450 million program at year-end; the board removed the program's expiration date in October 2025. Source

Portfolio and strategy

  • Divested segment shown as discontinued: Advanced Materials & Catalysts results are reported as discontinued operations for all periods presented in the statements. Source
  • Waggaman assets acquired in May: The May acquisition of Waggaman, Louisiana sulfuric acid assets for $41 million enhances the Gulf Coast network and adds capacity for future growth. Source
  • Divestiture called a portfolio milestone: Management described the divestiture as a key milestone in an ongoing portfolio transformation. Source

Coming up, as management said on 26 February 2026

  • Growth capital to be deployed in 2026: Management plans to deploy incremental growth capital in 2026 on projects it says will enhance customer service capability. Source
  • Inorganic growth and buybacks planned: Management plans to keep pursuing inorganic growth and an active share repurchase program. Source

Risks management discussed

  • Demand: Management said it remains cautious on near-term global macroeconomic activity and possible weakness in some industrial applications for virgin acid. Source
  • Operational: Unplanned and extended customer downtime lowered regenerated acid sales volume in the fourth quarter. Source
  • Operational: Higher manufacturing costs from general inflation, plus higher maintenance and transportation costs, largely offset volume and price gains at the sales level. Source

Earlier plans management reported on

  • Ahead: Management said full-year 2025 Adjusted EBITDA was above its guidance. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.